LGALS3 and hydrops fetalis: In the analysis, Gal-3 ≥ 6.49 ng/mL was associated with an increased risk of acute ischemic events, HF, or death (HR 3.26 (1.32–8.04), p = 0.010), along with a history of cerebrovascular events (HR 8.46 (2.06-34.8), p = 0.025) and treatment with insulin (HR 2.07 (1.06–4.02), p = 0.032).